Farabi Retina – Page 6 – Retina Ward- Farabi Eye Hospital-TUMS

The Future of Retinal Care: Understanding Subthreshold Micropulse Laser (SML) Therapy

For decades, laser treatment for retinal diseases meant "photocoagulation"—a process that, while effective, often left behind permanent scars and tissue damage. However, a newer approach called Subthreshold Micropulse Laser (SML)…

2026-07-03

Interesting Papers

The Manufacturing Edge: Aflibercept vs. Ranibizumab Biosimilars

The emergence of biosimilars has revolutionized the treatment landscape for retinal diseases. While ranibizumab biosimilars have led the way globally over the past few years, the recent FDA and EMA…

2026-07-02

Interesting Papers

Navigating Retinal and Choroidal Side Effects in Modern Cancer Therapy

The landscape of oncology has been transformed by systemic immunotherapies and targeted therapies, significantly improving survival rates for various cancers. However, as these treatments expand, ophthalmic adverse events (OAEs)—particularly those…

2026-07-02

Interesting Cases

The Silent Masquerade: Leveraging Multimodal Imaging to Unmask Intraocular Lymphoma

Intraocular lymphoma remains one of the most challenging "masquerade syndromes" in ophthalmology. These rare malignancies, which include vitreoretinal lymphoma (VRL) and choroidal lymphoma (CL), frequently simulate benign inflammatory conditions, often…

2026-07-02

Interesting Papers

The Visual Bridge: Integrating Histology and Multimodal Imaging in AMD Management

For the modern retina specialist, the management of age-related macular degeneration (AMD) has evolved from simple observation to a high-resolution analysis of the photoreceptor–retinal pigment epithelium (RPE)–choroid unit. Bridging the…

2026-07-01

Interesting Papers

Beyond the Repair: Is It Time for Proactive 360° RRD Prevention?

As retina specialists, we have witnessed a remarkable evolution in the management of rhegmatogenous retinal detachment (RRD). Since Jules Gonin first identified the retinal break as the primary etiology in…

2026-06-28

Interesting Papers

Beyond the Drusen: Modernizing AMD Staging with Multimodal Imaging

Age-related macular degeneration (AMD) remains the leading cause of irreversible vision loss in developed countries, with its global prevalence expected to soar to 288 million by 2040. While our ability…

2026-06-28

Interesting Papers

The Future of ROP Management: Navigating the Era of Multimodal AI

Retinopathy of prematurity (ROP) remains a leading cause of preventable childhood blindness globally, particularly as neonatal intensive care survival rates improve in low-resource regions. For the retina specialist and pediatric…

2026-06-24

Interesting Cases Interesting Papers

Healing Without the Knife: The Surprising Shift Toward Non-Surgical Macular Hole Recovery

For decades, the "gold standard" for treating a full-thickness macular hole (FTMH) has been immediate surgery—specifically, a pars plana vitrectomy. However, a growing body of clinical evidence is challenging this…

2026-06-22

The Future of Retinal Care: Understanding Subthreshold Micropulse Laser (SML) Therapy

The Manufacturing Edge: Aflibercept vs. Ranibizumab Biosimilars

Navigating Retinal and Choroidal Side Effects in Modern Cancer Therapy

The Silent Masquerade: Leveraging Multimodal Imaging to Unmask Intraocular Lymphoma

The Visual Bridge: Integrating Histology and Multimodal Imaging in AMD Management

Beyond the Repair: Is It Time for Proactive 360° RRD Prevention?

Beyond the Drusen: Modernizing AMD Staging with Multimodal Imaging

The Future of ROP Management: Navigating the Era of Multimodal AI

Healing Without the Knife: The Surprising Shift Toward Non-Surgical Macular Hole Recovery

Unmasking Knobloch Syndrome: Diagnostic Nuances, OCT Features, and Surgical Innovations in Retinal Detachment Repair

Unifying Macular Ischemic Syndromes: Pathophysiology, Multimodal Imaging, and Clinical Management of Coincident PAMM and AMN

Beyond the Retina: Leveraging SD-OCT Biomarkers to Uncover Systemic Cardiovascular & Neurodegenerative Disease

Deciphering MacTel Type 2 Progression: Biomarkers, Sigmoid Trajectories, and Implications for Therapeutic Intervention